Suppr超能文献

美洛西林在慢性血液透析患者中的处置情况。

Mezlocillin disposition in chronic hemodialysis patients.

作者信息

Janicke D M, Mangione A, Schultz R W, Jusko W J

出版信息

Antimicrob Agents Chemother. 1981 Nov;20(5):590-4. doi: 10.1128/AAC.20.5.590.

Abstract

The pharmacokinetics of a single 1-g intravenous dose of mezlocillin were examined in six functionally anephric patients undergoing hemodialysis. Hemodialysis clearance calculated by plasma extraction ratios across the dialyzer membrane and by dialysis fluid agree well, averaging 26 and 32 ml/min. Dialyzer extraction ratios averaged 0.16 +/- 0.07, and 23.3 +/- 9.6% of the dose was measured in the dialysate. Plasma clearances (104 +/- 45 ml/min) and steady-state volumes of distribution (0.22 +/- 0.07 liter/kg) of mezlocillin showed good agreement with literature values. The nonrenal clearance (4.25 +/- 2.30 liters/h per 1.73 m2) of mezlocillin was appreciable. Drug loss by hemodialysis is small and should have little effect on therapeutic dosage needs.

摘要

对6名接受血液透析的功能性无肾患者静脉注射1克美洛西林后的药代动力学进行了研究。通过透析器膜的血浆提取率和透析液计算出的血液透析清除率吻合良好,平均分别为26和32毫升/分钟。透析器提取率平均为0.16±0.07,在透析液中测得剂量的23.3±9.6%。美洛西林的血浆清除率(104±45毫升/分钟)和稳态分布容积(0.22±0.07升/千克)与文献值吻合良好。美洛西林的非肾清除率(每1.73平方米4.25±2.30升/小时)相当可观。血液透析造成的药物损失较小,对治疗剂量需求影响不大。

相似文献

1

本文引用的文献

8
Artificial kidneys and clearance calculations.
Clin Pharmacol Ther. 1976 Dec;20(6):720-6. doi: 10.1002/cpt1976206720.
10
Pharmacokinetics of mezlocillin in healthy volunteers.美洛西林在健康志愿者体内的药代动力学。
Antimicrob Agents Chemother. 1978 Dec;14(6):801-6. doi: 10.1128/AAC.14.6.801.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验